Rapratory Sycyntical Virus | American Lung Association

Location Select your location

Clinical Trials

Rapratory Sycyntical Virus

Institution:

National Institutes of Health

Type:

Individual Site

Purpose:

The purpose of the study is to see if the experimental vaccine is safe and if there are any side effects. We also want to study immune responses to the vaccine including cells that may recognize and fight RSV.

Dates:

January 2, 2017

Disease:

Pneumonia

Register:

clinicaltrials.gov

Contact:

VRC Recruitment
1-866-833-5433
clinicaltrials.gov

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.